โšกToday
โœจToday's leadDoctors Complete First Bone Marrow Transplant From Deceased Donor for Non-Malignant Disease๐ŸŽˆFor kidsSouth Carolina tract beside wildlife refuge to be permanently conserved๐ŸŒฟNatureFormer ocean liner S.S. United States becomes the world's largest artificial reefโšฝSportsLindy Duncan wins her first LPGA title on attempt 222๐ŸŽจCulture & ideasA Lost Altdorfer Landscape Surfaces After 70 Years Privately Held๐Ÿ”ฌScience & healthPeople who control HIV without treatment may help find a cure๐Ÿ’›KindnessA laid-off man began mowing lawns for free and 2,100 volunteers joined๐Ÿ›๏ธPoliticsLos Angeles bans oil drilling after a decade of neighborhood pressure๐Ÿš€ProgressPhiladelphia repaired a collapsed interstate in 12 days

Merck and Kelun drug cuts death risk in advanced endometrial cancer

STAT 26 October 2026 2 min read

โฎ BeforePatients with advanced endometrial cancer faced a higher risk of death on existing treatments.
โœ… NowIn a Phase 3 trial, a targeted drug cut that risk by one-third.

In short

  • A Phase 3 trial tested a targeted drug developed by Merck and China's Kelun-Biotech.
  • The drug cut the risk of death by one-third in patients with advanced endometrial cancer.
  • The source reports this as a trial result; the wider approval status is not stated.

Why it's good news

The trial measured a fall of about one-third in the risk of death for patients with advanced endometrial cancer. That is a large effect for a cancer where options can run short. The result comes from a Phase 3 trial, the stage that comes before wider approval, so the benefit still needs to be confirmed in routine care.

Advertisement

From STAT

A Phase 3 trial of a targeted drug developed by Merck and Chinaโ€™s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer.

Read the full story at STAT Opens the publisher's site in a new tab.

Ask this story

An AI model answers from the material behind this story only, with a link to the source. Your question is sent to our AI provider and isn't stored. See Privacy.

More like this

Advertisement
AdMobile anchor